Join
Live feed
·
PRReleasevia Quantisnow
Immunovant Inc. logo
Roivant Sciences Ltd. logo

Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.ROIV· Roivant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.), ROIV (Roivant Sciences Ltd.) and more on Quantisnow.